Evidence map›Paper›PMID 29921862›Full record

ArticleNature communications2018

Single-walled carbon-nanohorns improve biocompatibility over nanotubes by triggering less protein-initiated pyroptosis and apoptosis in macrophages.

Bing He, Yujie Shi, Yanqin Liang, Anpu Yang, Zhipu Fan, Lan Yuan, Xiajuan Zou, Xin Chang, Hua Zhang, Xueqing Wang and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 119 citations in OpenAlex.

  1. Review
  2. Insulin Detection Enabled by Sensors Employing Fluorescence Signal Amplification Strategy.Luminescence : the journal of biological and chemical luminescence · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Nanomaterials as protein mimics or nanologicals.Nanomedicine (London, England) · 2024
    Article
  14. Article
  15. Article
  16. Nanomaterial-induced pyroptosis: a cell type-specific perspective.Frontiers in cell and developmental biology · 2023
    Review
  17. Nanomedicine-Enabled/Augmented Cell Pyroptosis for Efficient Tumor Nanotherapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Review
  18. Understanding the immunological interactions of engineered nanomaterials: Role of the bio-corona.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Bing HeDepartment of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China.
Yujie ShiState Key Laboratory of Natural and Biomimetic Drugs, Beijing, 100191, China.
Yanqin LiangDepartment of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China.
Anpu YangDepartment of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China.
Zhipu FanDepartment of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China.
Lan YuanCentre of Medical and Health Analysis, Peking University, Beijing, 100191, China.
Xiajuan ZouCentre of Medical and Health Analysis, Peking University, Beijing, 100191, China.
Xin ChangCentre of Medical and Health Analysis, Peking University, Beijing, 100191, China.
Hua ZhangDepartment of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China.
Xueqing WangDepartment of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China.
Wenbin DaiDepartment of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China.
Yiguang WangDepartment of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China.ORCID http://orcid.org/0000-0002-1676-4211
Qiang ZhangDepartment of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China. zqdodo@bjmu.edu.cn.
Peking University · CN

Funding

National Natural Science Foundation of China (National Science Foundation of China) 81690264
6 · The paper itself

Abstract

Single-walled carbon-nanohorns (SNH) exhibit huge application prospects. Notably, spherical SNH possess different morphology from conventional carbon nanotubes (CNT). However, there is a tremendous lack of studies on the nanotoxicity and mechanism of SNH, and their comparison with nanotubes. Here, the dissimilarity between SNH and CNT is found in many aspects including necrosis, pyroptosis, apoptosis, protein expression, hydrolases leakage, lysosome stress, membrane disturbance and the interaction with membrane proteins. The improved biocompatibility of SNH over four types of established CNT is clearly demonstrated in macrophages. Importantly, a key transmembrane protein, glycoprotein nonmetastatic melanoma protein B (GPNMB) is discovered to initiate the nanotoxicity. Compared to CNT, the weaker nano-GPNMB interaction in SNH group induces lower degree of cascade actions from nano/membrane interplay to final cell hypotoxicity. In conclusion, the geometry of single-construct unit, but not that of dispersive forms or intracellular levels of nanocarbons make the most difference.

Indexed as

AnimalsApoptosisBiocompatible MaterialsCell LineCell SurvivalEye ProteinsMacrophagesMembrane GlycoproteinsMiceNanostructuresNanotubes, CarbonProteinsPyroptosisBiocompatible MaterialsEye ProteinsGpnmb protein, mouseMembrane GlycoproteinsNanotubes, CarbonProteins

Identifiers

PMID29921862
PMCPMC6008334
OpenAlexW2808045932

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.